Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,000
Closed -$158K 71
2023
Q4
$158K Hold
50,000
0.09% 71
2023
Q3
$145K Hold
50,000
0.1% 62
2023
Q2
$179K Hold
50,000
0.12% 72
2023
Q1
$197K Hold
50,000
0.17% 60
2022
Q4
$179K Hold
50,000
0.17% 54
2022
Q3
$161K Sell
50,000
-100,000
-67% -$330K 0.18% 55
2022
Q2
$509K Buy
+150,000
New +$626K 0.5% 39
2022
Q1
Sell
-150,000
Closed -$590K 84
2021
Q4
$590K Buy
150,000
+50,000
+50% +$201K 0.28% 64
2021
Q3
$342K Buy
+100,000
New +$386K 0.16% 75
2020
Q4
Sell
-23,000
Closed -$150K 99
2020
Q3
$150K Buy
23,000
+8,000
+53% +$52K 0.09% 81
2020
Q2
$85K Buy
+15,000
New +$75.2K 0.06% 78

Other funds holding BTG

Geneva Partners's BTG Position: Q1 2024 in Review

Geneva Partners sold out of B2Gold (BTG) in Q1 2024, closing a stake of 50,000 shares — an estimated $158K sold.

Geneva Partners first reported a position in BTG in Q2 2020 and held it in 11 quarters. The position peaked at $590K in Q4 2021. 251 funds tracked by Wall St. Rank hold BTG as of Q1 2024.

  • Geneva Partners reported no remaining B2Gold position as of Q1 2024 after selling out during the quarter.
  • Geneva Partners sold 50,000 B2Gold shares in Q1 2024, an estimated $158K.
  • Geneva Partners first reported a position in B2Gold in Q2 2020 and held it in 11 quarters.
  • Geneva Partners's B2Gold position peaked at $590K in Q4 2021.
  • 251 funds tracked by Wall St. Rank held B2Gold as of Q1 2024.

Based on Geneva Partners's 13F filing for Q1 2024, filed 30 Apr 2024.